254 related articles for article (PubMed ID: 9022747)
21. Synthesis, DNA-binding and cytotoxic properties of a bis(netropsin)-anthracenedione conjugate.
Boitte N; Pommery N; Colson P; Houssier C; Waring MJ; Hénichart JP; Bailly C
Anticancer Drug Des; 1997 Sep; 12(6):481-501. PubMed ID: 9311557
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and evaluation of substituted naphthalimide nitrogen mustards as rationally designed anticancer compounds.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Quazi GN; Sanyal U
Acta Pol Pharm; 2003; 60(4):285-91. PubMed ID: 14714857
[TBL] [Abstract][Full Text] [Related]
23. Selective DNA interaction of the novel distamycin derivative FCE 24517.
Broggini M; Erba E; Ponti M; Ballinari D; Geroni C; Spreafico F; D'Incalci M
Cancer Res; 1991 Jan; 51(1):199-204. PubMed ID: 1859575
[TBL] [Abstract][Full Text] [Related]
24. Role of DNA minor groove alkylation and DNA cross-linking in the cytotoxicity of polybenzamide mustards.
Turner PR; Denny WA; Ferguson LR
Anticancer Drug Des; 2000 Aug; 15(4):245-53. PubMed ID: 11200500
[TBL] [Abstract][Full Text] [Related]
25. Combinatorial identification of a novel consensus sequence for the covalent DNA-binding polyamide tallimustine.
Sunavala-Dossabhoy G; Van Dyke MW
Biochemistry; 2005 Feb; 44(7):2510-22. PubMed ID: 15709763
[TBL] [Abstract][Full Text] [Related]
26. Molecular modelling, synthesis and antitumour activity of carbocyclic analogues of netropsin and distamycin--new carriers of alkylating elements.
Bartulewic D; Markowska A; Wołczyński S; Dabrowska M; Rózański A
Acta Biochim Pol; 2000; 47(1):23-35. PubMed ID: 10961675
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of novel chloroethylaminoanthraquinones with potent cytotoxic activity against cisplatin-resistant tumor cells.
Pors K; Paniwnyk Z; Ruparelia KC; Teesdale-Spittle PH; Hartley JA; Kelland LR; Patterson LH
J Med Chem; 2004 Mar; 47(7):1856-9. PubMed ID: 15027879
[TBL] [Abstract][Full Text] [Related]
28. A New Cross-Link for an Old Cross-Linking Drug: The Nitrogen Mustard Anticancer Agent Mechlorethamine Generates Cross-Links Derived from Abasic Sites in Addition to the Expected Drug-Bridged Cross-Links.
Nejad MI; Johnson KM; Price NE; Gates KS
Biochemistry; 2016 Dec; 55(50):7033-7041. PubMed ID: 27992994
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, DNA binding, cytotoxicity and sequence specificity of a series of imidazole-containing analogs of the benzoic acid mustard distamycin derivative tallimustine containing an alkylating group at the C-terminus.
Brooks N; Lee M; Wright SR; Woo S; Centioni S; Hartley JA
Anticancer Drug Des; 1997 Oct; 12(7):591-606. PubMed ID: 9365504
[TBL] [Abstract][Full Text] [Related]
30. Polybenzamide mustards: structure-activity relationships for DNA sequence-specific alkylation.
Turner PR; Ferguson LR; Denny WA
Anticancer Drug Des; 1999 Feb; 14(1):61-70. PubMed ID: 10363028
[TBL] [Abstract][Full Text] [Related]
31. Structure of the d(CGCGAATTCGCG)2 complex of the minor groove binding alkylating agent alkamin studied by mass spectrometry.
Majid AM; Smythe G; Denny WA; Wakelin LP
Mol Pharmacol; 2007 Apr; 71(4):1165-78. PubMed ID: 17251328
[TBL] [Abstract][Full Text] [Related]
32. Anomalous cross-linking by mechlorethamine of DNA duplexes containing C-C mismatch pairs.
Romero RM; Mitas M; Haworth IS
Biochemistry; 1999 Mar; 38(12):3641-8. PubMed ID: 10090751
[TBL] [Abstract][Full Text] [Related]
33. DNA minor groove alkylating agents.
Denny WA
Curr Med Chem; 2001 Apr; 8(5):533-44. PubMed ID: 11281840
[TBL] [Abstract][Full Text] [Related]
34. Non-covalent ligand/DNA interactions: minor groove binding agents.
Nelson SM; Ferguson LR; Denny WA
Mutat Res; 2007 Oct; 623(1-2):24-40. PubMed ID: 17507044
[TBL] [Abstract][Full Text] [Related]
35. DNA alkylation by minor groove-binding N1-alkoxyalkyl-bis-benzimidazoles.
Gupta R; Huang L; Wang H; Lown JW
Anticancer Drug Des; 1995 Sep; 10(6):451-61. PubMed ID: 7575987
[TBL] [Abstract][Full Text] [Related]
36. The 5'-GNC preference for mustard cross-linking is preserved in a restriction fragment.
Millard JT; Luedtke NW; Spencer RJ
Anticancer Drug Des; 1996 Sep; 11(6):485-92. PubMed ID: 8836112
[No Abstract] [Full Text] [Related]
37. Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders.
Baraldi PG; Balboni G; Pavani MG; Spalluto G; Tabrizi MA; Clercq ED; Balzarini J; Bando T; Sugiyama H; Romagnoli R
J Med Chem; 2001 Aug; 44(16):2536-43. PubMed ID: 11472207
[TBL] [Abstract][Full Text] [Related]
38. Self-immolative nitrogen mustard prodrugs for suicide gene therapy.
Niculescu-Duvaz D; Niculescu-Duvaz I; Friedlos F; Martin J; Spooner R; Davies L; Marais R; Springer CJ
J Med Chem; 1998 Dec; 41(26):5297-309. PubMed ID: 9857097
[TBL] [Abstract][Full Text] [Related]
39. The mechanism of guanine alkylation by nitrogen mustards: a computational study.
Polavarapu A; Stillabower JA; Stubblefield SG; Taylor WM; Baik MH
J Org Chem; 2012 Jul; 77(14):5914-21. PubMed ID: 22681226
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, DNA binding and cytotoxicity of 1-[[omega-(9-acridinyl)amino]alkyl]carbonyl -3-(chloromethyl)-6-hydroxyindolines, a new class of DNA-targeted alkylating agents.
Fan JY; Tercel M; Denny WA
Anticancer Drug Des; 1997 Jun; 12(4):277-93. PubMed ID: 9199660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]